Dexamethasone is non-inferior to antihistamine plus dexamethasone premedication in preventing ramucirumab plus nab-paclitaxel infusion-related reactions in gastric cancer: a multicenter retrospective study
RAM plus nab-PTX for gastric cancer with DEX premedication may be possible without H<sub>1</sub>RA premedication.
Authors
- Yukio Kamitani
- Yutaka Negoro (ORCID: https://orcid.org/0000-0003-0440-8380)
- Toshihiro Tanaka (ORCID: https://orcid.org/0000-0001-6201-9784)
- Hitoshi Tsukamoto (ORCID: https://orcid.org/0000-0002-9254-1781)
- Nobuyuki Goto (ORCID: https://orcid.org/0000-0002-0139-3876)
- Kyohei Watanabe (ORCID: https://orcid.org/0000-0002-1171-9948)
- Norihiko Tanizawa
- Hiroyuki Igarashi
- J Ogawa
- Taichi Maeda
- Mina Shigemori
- Yukio Ito
- Shota Nishikawa
Institutions
- Fukui Red Cross Hospital (JP)
- University of Fukui Hospital (JP)
- Fukui-ken Saiseikai Hospital (JP)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1007/s00520-024-08910-8
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Fukui